These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 1192606)
21. Synthesis of S-lactoyl-glutathione using glyoxalase I bound to sepharose 4B. Piskorska D; Jerzykowski T; Ostrowska M Experientia; 1976 Nov; 32(11):1382-3. PubMed ID: 991975 [TBL] [Abstract][Full Text] [Related]
22. Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy. Kar NC; Pearson CM Neurology; 1973 May; 23(5):478-82. PubMed ID: 4735464 [No Abstract] [Full Text] [Related]
23. [Glyoxalase I and its application to production of S-lactoylglutathione]. Rhee H; Kimura A Tanpakushitsu Kakusan Koso; 1988 Jul; 33(9):1610-4. PubMed ID: 3074382 [No Abstract] [Full Text] [Related]
24. [AMP-aminohydrolase of skeletal muscles in muscular diseases]. Niebrój-Dobosz I; Strumień M Neurol Neurochir Pol; 1979; 13(4):383-7. PubMed ID: 481690 [TBL] [Abstract][Full Text] [Related]
25. Characterization of protein kinase system in human skeletal muscle. Frattola L; Pellegrini G; Tonini C; Scarlato G J Neurol Sci; 1980 Mar; 45(2-3):349-54. PubMed ID: 6245188 [TBL] [Abstract][Full Text] [Related]
28. Glyoxalase activity in quiescent and proliferating human fibroblasts. Bruschelli G; Mariucci G; Principato GB; Liotti FS Cell Mol Biol; 1986; 32(2):183-5. PubMed ID: 3708662 [No Abstract] [Full Text] [Related]
29. ABNORMAL MYOGLOBIN ULTRAVIOLET SPECTRUM IN DUCHENNE TYPE OF PROGRESSIVE MUSCULAR DYSTROPHY. MIYOSHI K; SAIJO K; KURYU Y; OSHIMA Y Science; 1963 Oct; 142(3591):490-1. PubMed ID: 14064446 [TBL] [Abstract][Full Text] [Related]
30. [Activity of glyoxalase and glyoxalase II under the effect of toxohormone from melanoma]. Winter R; Piskorska D; Jerzykowski T; Grabowska AM Patol Pol; 1980; 31(1):35-40. PubMed ID: 7190262 [No Abstract] [Full Text] [Related]
31. [Enzyme patterns of healthy and pathologically changed human muscles]. Kleine TO Z Klin Chem Klin Biochem; 1967 Sep; 5(5):244-7. PubMed ID: 4248138 [No Abstract] [Full Text] [Related]
32. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Metzinger L; Blake DJ; Squier MV; Anderson LV; Deconinck AE; Nawrotzki R; Hilton-Jones D; Davies KE Hum Mol Genet; 1997 Jul; 6(7):1185-91. PubMed ID: 9215691 [TBL] [Abstract][Full Text] [Related]
33. Radioimmunoassay of human muscle carbonic anhydrase III in dystrophic states. Heath R; Jeffery S; Carter N Clin Chim Acta; 1982 Mar; 119(3):299-305. PubMed ID: 6802521 [TBL] [Abstract][Full Text] [Related]
34. [Creatine phosphokinase activities in various skeletal muscles in a case of progressive muscular dystrophy (Duchenne type). Enzymatic measurements at autopsy]. Araki S; Inokuchi T; Narazaki T Igaku To Seibutsugaku; 1967 Oct; 75(4):145-8. PubMed ID: 5627037 [No Abstract] [Full Text] [Related]
35. Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture. Mawatari S; Miranda A; Rowland LP Neurology; 1976 Nov; 26(11):1021-6. PubMed ID: 988507 [TBL] [Abstract][Full Text] [Related]
36. Octahedral metal coordination in the active site of glyoxalase I as evidenced by the properties of Co(II)-glyoxalase I. Sellin S; Eriksson LE; Aronsson AC; Mannervik B J Biol Chem; 1983 Feb; 258(4):2091-3. PubMed ID: 6296126 [TBL] [Abstract][Full Text] [Related]
37. Calcium activated neutral proteases (milli- and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). Reddy PA; Anandavalli TE; Anandaraj MP Clin Chim Acta; 1986 Nov; 160(3):281-8. PubMed ID: 3024865 [TBL] [Abstract][Full Text] [Related]
38. AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies. Nagao H; Habara S; Morimoto T; Sano N; Takahashi M; Kida K; Matsuda H Neuropediatrics; 1986 Nov; 17(4):193-8. PubMed ID: 3808228 [TBL] [Abstract][Full Text] [Related]